China Pharma Holdings Inc.

0.2301-0.0044-1.88%Vol 328.46K1Y Perf -73.89%
Aug 9th, 2022 15:55 DELAYED
BID0.2300 ASK0.2301
Open0.2300 Previous Close0.2345
Pre-Market- After-Market0.23
 - -  0.00 -0.04%
Target Price
- 
Analyst Rating
— 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
+     34.50
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
     17.92
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
5.27 
Earnings Rating
Buy
Market Cap11.11M 
Earnings Date
12th Aug 2022
Alpha0.02 Standard Deviation0.26
Beta0.51 

Today's Price Range

0.21500.2479

52W Range

0.19010.9498

5 Year PE Ratio Range

-5.80-1.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
7.82%
1 Month
7.13%
3 Months
-10.15%
6 Months
-50.62%
1 Year
-73.89%
3 Years
-13.15%
5 Years
23.42%
10 Years
-48.91%

TickerPriceChg.Chg.%
CPHI0.2301-0.0044-1.88
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
-1.10
-34.50
0.40
-96.60
-43.66
RevenueValueIndustryS&P 500US Markets
6.47M
0.13
-6.02
-8.05
Earnings HistoryEstimateReportedSurprise %
Q01 2022--0.02-
Q03 2021--0.02-
Q02 2021--0.02-
Q01 2021--0.02-
Q03 2020--0.02-
Q02 2020-0.00-
Q01 2020--0.02-
Q04 2019--0.43-
Earnings Per EndEstimateRevision %Trend
3/2012 QR---
6/2012 QR---
12/2012 FY---
12/2013 FY---
Next Report Date12th Aug 2022
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume328.46K
Shares Outstanding48.30K
Shares Float25.18M
Trades Count618
Dollar Volume78.15K
Avg. Volume538.83K
Avg. Weekly Volume964.89K
Avg. Monthly Volume351.49K
Avg. Quarterly Volume300.12K

China Pharma Holdings Inc. (AMEX: CPHI) stock closed at 0.2345 per share at the end of the most recent trading day (a 11.35% change compared to the prior day closing price) with a volume of 628.28K shares and market capitalization of 11.11M. Is a component of indices and it is traded on AMEX exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 242 people. China Pharma Holdings Inc. CEO is Zhilin Li.

The one-year performance of China Pharma Holdings Inc. stock is -73.89%, while year-to-date (YTD) performance is -51.41%. CPHI stock has a five-year performance of 23.42%. Its 52-week range is between 0.1901 and 0.9498, which gives CPHI stock a 52-week price range ratio of 5.27%

China Pharma Holdings Inc. currently has a PE ratio of -2.60, a price-to-book (PB) ratio of 1.86, a price-to-sale (PS) ratio of 1.54, a price to cashflow ratio of 62.10, a PEG ratio of 2.32, a ROA of -18.41%, a ROC of -19.44% and a ROE of -60.49%. The company’s profit margin is -43.66%, its EBITDA margin is 0.40%, and its revenue ttm is $6.47 Million , which makes it $0.13 revenue per share.

Of the last four earnings reports from China Pharma Holdings Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. China Pharma Holdings Inc.’s next earnings report date is 12th Aug 2022.

The consensus rating of Wall Street analysts for China Pharma Holdings Inc. is (0), with a target price of $, which is 0.00% compared to the current price. The earnings rating for China Pharma Holdings Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

China Pharma Holdings Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

China Pharma Holdings Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 31.40, ATR14 : 0.02, CCI20 : 175.35, Chaikin Money Flow : -0.23, MACD : 0.00, Money Flow Index : 73.85, ROC : 12.93, RSI : 57.53, STOCH (14,3) : 56.78, STOCH RSI : 1.00, UO : 38.34, Williams %R : -43.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of China Pharma Holdings Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
1 (100.00 %)
Moderate Buy
0
0
0 (0.00 %)
Hold
0
0
0 (0.00 %)
Moderate Sell
0
0
0 (0.00 %)
Strong Sell
0
0
0 (0.00 %)
Summary Rating-
0.00
-
0.00
Strong Buy
1.00

China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablet, clarithromycin granule, roxithromycin dispersible tablet, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

CEO: Zhilin Li

Telephone: +86 89866811730

Address: Second Floor, No. 17, Jinpan Road, Haikou 570216, , CN

Number of employees: 242

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

63%38%

Bearish Bullish

61%39%


News

Stocktwits